Cardiometabolic Health and Bariatric Surgery: A 25-Year Longitudinal Cohort Study in CARDIA Participants.

Brian T Steffen, Sayeed Ikramuddin, David R Jacobs, Kristi L Kopacz, Daniel Duprez, Ankeet S Bhatt, Jamal S Rana, John J Carr, Xia Zhou, Lyn M Steffen
{"title":"Cardiometabolic Health and Bariatric Surgery: A 25-Year Longitudinal Cohort Study in CARDIA Participants.","authors":"Brian T Steffen, Sayeed Ikramuddin, David R Jacobs, Kristi L Kopacz, Daniel Duprez, Ankeet S Bhatt, Jamal S Rana, John J Carr, Xia Zhou, Lyn M Steffen","doi":"10.1097/AS9.0000000000000609","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Compare longitudinal cardiometabolic health outcomes among individuals who underwent bariatric surgery (BarS) with nonsurgical controls.</p><p><strong>Background: </strong>BarS is well-established for inducing profound weight loss and improving cardiometabolic health, but it remains unclear whether patients achieve long-term cardiometabolic health consistent with the attained lower weight status.</p><p><strong>Methods: </strong>Cohort study participants who underwent any BarS procedure between 1987 and 2021 (n = 94) were paired with sex- and body mass index (BMI)-matched nonsurgical controls (n = 282) at the nearest postoperative cohort exam visit (2.8 ± 1.7 years following surgery). A mixed model tested differences between BarS cases and nonsurgical matched controls, adjusting for age, sex, race, field center, and maximal education attainment. Intermediate cardiometabolic endpoints and incident diabetes and metabolic syndrome, were examined at follow-up exam visits.</p><p><strong>Results: </strong>Approximately 7.5 years following their procedures, those who underwent BarS showed higher BMIs than matched controls (+2.8 kg/m<sup>2</sup>); however, the BarS group showed significantly lower mean fasting levels of glucose (-6.5 mg/dL; <i>P</i> = 0.03), insulin (-2.75 μU/mL; <i>P</i> = 0.01), low density lipoprotein cholesterol (-20.0 mg/dL; <i>P</i> < 0.001), C-reactive protein (log-transformed) (-0.42; <i>P</i> = 0.002), homeostasis model assessment-estimated insulin resistance (-0.75; <i>P</i> = 0.02), and higher mean high density lipoprotein cholesterol (+11.4 mg/dL; <i>P</i> < 0.001) compared to matched controls. BarS cases showed lower incidence of diabetes (1.8% vs 11.7%; <i>P</i> = 0.007) and nominally lower MetS (13.7% vs 22.3%; <i>P</i> = 0.23).</p><p><strong>Conclusions: </strong>We found no evidence of lasting adverse cardiometabolic health consequences of severe obesity in a sample of cohort participants who underwent a BarS procedure. On average, BarS cases showed features of better cardiometabolic health than postoperative-matched nonsurgical controls who followed a more moderate trajectory of obesity.</p>","PeriodicalId":72231,"journal":{"name":"Annals of surgery open : perspectives of surgical history, education, and clinical approaches","volume":"6 3","pages":"e609"},"PeriodicalIF":0.0000,"publicationDate":"2025-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12453380/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of surgery open : perspectives of surgical history, education, and clinical approaches","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/AS9.0000000000000609","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/9/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: Compare longitudinal cardiometabolic health outcomes among individuals who underwent bariatric surgery (BarS) with nonsurgical controls.

Background: BarS is well-established for inducing profound weight loss and improving cardiometabolic health, but it remains unclear whether patients achieve long-term cardiometabolic health consistent with the attained lower weight status.

Methods: Cohort study participants who underwent any BarS procedure between 1987 and 2021 (n = 94) were paired with sex- and body mass index (BMI)-matched nonsurgical controls (n = 282) at the nearest postoperative cohort exam visit (2.8 ± 1.7 years following surgery). A mixed model tested differences between BarS cases and nonsurgical matched controls, adjusting for age, sex, race, field center, and maximal education attainment. Intermediate cardiometabolic endpoints and incident diabetes and metabolic syndrome, were examined at follow-up exam visits.

Results: Approximately 7.5 years following their procedures, those who underwent BarS showed higher BMIs than matched controls (+2.8 kg/m2); however, the BarS group showed significantly lower mean fasting levels of glucose (-6.5 mg/dL; P = 0.03), insulin (-2.75 μU/mL; P = 0.01), low density lipoprotein cholesterol (-20.0 mg/dL; P < 0.001), C-reactive protein (log-transformed) (-0.42; P = 0.002), homeostasis model assessment-estimated insulin resistance (-0.75; P = 0.02), and higher mean high density lipoprotein cholesterol (+11.4 mg/dL; P < 0.001) compared to matched controls. BarS cases showed lower incidence of diabetes (1.8% vs 11.7%; P = 0.007) and nominally lower MetS (13.7% vs 22.3%; P = 0.23).

Conclusions: We found no evidence of lasting adverse cardiometabolic health consequences of severe obesity in a sample of cohort participants who underwent a BarS procedure. On average, BarS cases showed features of better cardiometabolic health than postoperative-matched nonsurgical controls who followed a more moderate trajectory of obesity.

Abstract Image

Abstract Image

Abstract Image

心脏代谢健康和减肥手术:一项针对CARDIA参与者的25年纵向队列研究
目的:比较接受减肥手术(BarS)和非手术对照者的纵向心脏代谢健康结果。背景:BarS在诱导深度减肥和改善心脏代谢健康方面是公认的,但目前尚不清楚患者是否能达到与获得的较低体重状态相一致的长期心脏代谢健康。方法:在1987年至2021年期间接受任何BarS手术的队列研究参与者(n = 94)在最近的术后队列检查访问(手术后2.8±1.7年)时与性别和体重指数(BMI)匹配的非手术对照组(n = 282)配对。一个混合模型测试了BarS病例和非手术匹配对照之间的差异,调整了年龄、性别、种族、场地中心和最大教育程度。在随访检查中检查中间心脏代谢终点和糖尿病和代谢综合征的发生率。结果:手术后大约7.5年,接受BarS治疗的患者的bmi高于对照组(+2.8 kg/m2);然而,与匹配的对照组相比,BarS组的平均空腹血糖(-6.5 mg/dL, P = 0.03)、胰岛素(-2.75 μU/mL, P = 0.01)、低密度脂蛋白胆固醇(-20.0 mg/dL, P < 0.001)、c反应蛋白(log-transformed) (-0.42, P = 0.002)、稳态模型评估-估计的胰岛素抵抗(-0.75,P = 0.02)和平均高密度脂蛋白胆固醇(+11.4 mg/dL, P < 0.001)水平显著降低。BarS患者的糖尿病发病率较低(1.8% vs 11.7%, P = 0.007),名义上met较低(13.7% vs 22.3%, P = 0.23)。结论:我们在接受bar手术的队列参与者样本中没有发现严重肥胖的持续不良心脏代谢健康后果的证据。平均而言,BarS患者的心脏代谢健康状况优于术后匹配的非手术对照组,后者遵循更温和的肥胖轨迹。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
审稿时长
3 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信